LIZ DOOLIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Neuphoria Therapeutics Inc.

Filing Date Source Excerpt
2024-11-12 Liz Doolin Includes (i) 127,629 shares and (ii) 3,000,000 shares that Ms. Doolin has the right to acquire pursuant to options that are exercisable as of October 31, 2024, or will become exercisable within 60 days of such date.

Data sourced from SEC filings. Last updated: 2026-02-03